What is your process for obtaining and using next generation sequencing on patients with advanced endometrial cancer?  

All patients initially have IHC done for MMR deficiency and then may go on to genetic testing, based on the results. Additionally, we send tumor to Foundation Medicine for sequencing which includes POLE mutations etc., and also for PDL1.